Metabolic Disorders
GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Metabolic Disorders market. Reports cover market growth forecasts, trends and research, and more.
Browse our full list of Metabolic Disorders market reports here.
- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
- The Price Conversion is only for the Indicative purpose.
- USD — US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
-
Product Insights
Tay-Sachs Disease Global Clinical Trials Review, H2, 2016 Tay-Sachs Disease Global Clinical Trials Review, H2, 2016
$2,500 | October 2016 GlobalData's clinical trial report, “Tay-Sachs Disease Global Clinical Trials Review, H2, 2016" provides an overview of Tay-Sachs Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Tay-Sachs Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Becker Muscular Dystrophy Global Clinical Trials Review, H2, 2016 Becker Muscular Dystrophy Global Clinical Trials Review, H2, 2016
$2,500 | October 2016 GlobalData's clinical trial report, “Becker Muscular Dystrophy Global Clinical Trials Review, H2, 2016" provides an overview of Becker Muscular Dystrophy clinical trials scenario. This report provides top line data relating to the clinical trials on Becker Muscular Dystrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2016 Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2016
$2,500 | November 2016 GlobalData's clinical trial report, “Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2016" provides an overview of Glycogen Storage Disorders (GSD) clinical trials scenario. This report provides top line data relating to the clinical trials on Glycogen Storage Disorders (GSD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2016 Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2016
$2,500 | November 2016 GlobalData's clinical trial report, “Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2016" provides an overview of Alpha- Antitrypsin Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Alpha- Antitrypsin Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Fabry Disease Global Clinical Trials Review, H2, 2016 Fabry Disease Global Clinical Trials Review, H2, 2016
$2,500 | November 2016 GlobalData's clinical trial report, “Fabry Disease Global Clinical Trials Review, H2, 2016" provides an overview of Fabry Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Fabry Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cystinosis Global Clinical Trials Review, H2, 2016 Cystinosis Global Clinical Trials Review, H2, 2016
$2,500 | November 2016 GlobalData's clinical trial report, “Cystinosis Global Clinical Trials Review, H2, 2016" provides an overview of Cystinosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystinosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
EpiCast Report: Hyperparathyroidism – Epidemiology Forecast to 2025 EpiCast Report: Hyperparathyroidism – Epidemiology Forecast to 2025
$3,995 | December 2016 HPT is a disorder of the parathyroid gland that is caused due to presence of excessive parathyroid hormone (PTH) in the bloodstream. An increase in the activity of parathyroid glands, due to intrinsic abnormal changes, causes alteration of the excretion of PTH, and is known as PHPT. However, an extrinsic abnormal change affecting calcium homoeostasis, which stimulates production of PTH, is known as SHPT. In THPT, a state of autonomous secretion of PTH usually occurs as a result of longstanding...
-
Product Insights
Pompe Disease Global Clinical Trials Review, H1, 2016 Pompe Disease Global Clinical Trials Review, H1, 2016
$2,500 | February 2016 GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H1, 2016" provides an overview of Pompe Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Pompe Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diffuse Diabetic Macular Edema Global Clinical Trials Review, H1, 2016 Diffuse Diabetic Macular Edema Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Diffuse Diabetic Macular Edema Global Clinical Trials Review, H1, 2016" provides an overview of Diffuse Diabetic Macular Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Diffuse Diabetic Macular Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016 Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016" provides an overview of Familial Chylomicronemia (Type I Hyperlipoproteinemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Familial Chylomicronemia (Type I Hyperlipoproteinemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.